Department of Oncology, Radiotherapy and Reconstructive Surgery, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Moskva, Russia
Dr. Stiven Yusufov
Department of Oncology, Radiotherapy and Reconstructive Surgery, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Moskva, Russia
Background/Objectives: Robotic breast reconstruction is an innovative surgical technique that integrates robotic technology into breast reconstruction procedures, offering several advantages over conventional approaches. These benefits include enhanced visualization, increased surgical dexterity, and superior cosmetic outcomes. This study aims to comprehensively compare robotic-assisted and conventional breast reconstruction approaches in terms of complication profiles and operation-related measurements. Methods: A comprehensive search was conducted in PubMed, Embase, Scopus, Web of Science, Google Scholar, CENTRAL, and VHL from inception to October 2024 to identify relevant studies. Risk ratios for the following complications were calculated between the groups: donor site seroma, hematoma, infection, and unplanned reoperation. Mean differences were also calculated for the duration of surgery, length of postoperative hospital stays, and opioid use. Results: A meta-analysis was performed on 9 studies including a total of 1094 patients. No significant differences were found between the groups in the risk ratios for reoperation, seroma formation, delayed healing, infections, and hematomas. Similarly, there were no significant differences in postoperative opioid use. The duration of surgery was longer in the robot-assisted reconstruction group, whereas the duration of hospital stay was shorter compared to the conventional group. Meta-regression analysis for the duration of surgery model showed that none of the moderators had a statistically significant effect on this outcome. ROBINS-I assessment indicated that all the included studies had a serious risk of bias. Conclusions: Our results suggest that using a robot-assisted approach is associated with a shorter duration of hospital stay and a longer duration of surgery.
28 July 2024 in The American Journal of Cosmetic Surgery
Introduction: The aim of this study is to comprehensively compare breast modification surgeries using smooth and textured implants in terms of a complication profile. Materials and methods: PubMed, ScienceDirect, Embase, and Cochrane databases were searched for relevant studies reporting complication rates and quality of life on the BREAST-Q questionnaire in groups of patients with smooth and textured implants. The odds ratios of the following complications between the groups were calculated: capsular contracture, hematoma, infection, malposition, seroma, breast rippling, implant rupture, and reoperation rates. And mean differences for BREAST-Q scores were also calculated. Results: A meta-analysis of 14 studies was performed in this article. No significant differences were found in the odds of capsular contracture, malposition, seroma, breast rippling, implant rupture, and reoperation rates between groups. The chance of developing infection was statistically significantly lower with smooth implants. The chance of hematoma development was statistically significantly lower with textured implants. Comparison of BREAST-Q results showed no difference between the groups. Conclusion: Our results suggest that using smooth implants is associated with a lower chance of infection and a higher chance of hematoma development.
30 March 2026 in Plastic Surgery and Aesthetic Medicine
Objective. To study topographic and anatomical features of lumbar perforator blood supply for breast reconstruction. Material and methods. The study included 20 unfixed human female cadavers (aged 63—75 years). We assessed vascular anatomy of the flap, length of the vascular pedicle and flap, width of the flap and exact location of L4 perforator on both sides. Results and conclusion. The LAP (lumbar artery perforator) flap appears to be a potentially useful option for autologous breast reconstruction, and the identified landmarks may facilitate preoperative planning. Further clinical studies are advisable to clarify parameters and evaluate clinical outcomes considering small length of vascular pedicle.
This critical narrative review examines clinical outcomes of therapeutic lymphaticovenular anastomosis (LVA) for established breast cancer-related lymphedema and proposes a coordinated outcome assessment. MEDLINE/PubMed, Embase, Scopus, the Cochrane Library, and ClinicalTrials.gov were searched through 6 September 2026. Comparative studies were selected purposively, with clinical series, imaging and physiological studies, and evidence syntheses providing context. We examined outcomes, comparators, follow-up, and study limitations without quantitative pooling. A six-month interim randomized analysis found no convincing between-group differences in the total Lymphedema Functioning, Disability and Health (Lymph-ICF) score or volume measures. The physical domain and reported compression use favored LVA plus conservative treatment. These findings require consideration of outcome hierarchy and multiple comparisons. Selected observational studies reported improvements but were vulnerable to confounding. The proposed framework coordinates a minimum clinical dataset, including prescribed and actual compression use, with optional measurements of anastomosis status, transport, and tissue characteristics. It aligns technical and clinical assessments over time to explore their relationship. The selected clinical findings suggest possible benefits in symptoms and treatment burden but do not establish sustained independence from compression. The framework is a research proposal and does not provide validated rules for patient selection.